Advanced Enzyme Technologies · NSE: ADVENZYMES · BSE: 540025

Q1 FY26 results · Apr–Jun 2025

Advanced Enzyme Technologies reported revenue from operations of ₹185.91 crore (up 20.3% from Q1 FY25) and net profit of ₹40.44 crore (up 15.6% from Q1 FY25) for Q1 FY26 (Apr–Jun 2025), on a consolidated basis.

Consolidated · ₹ crore
ItemQ1 FY26Q1 FY25YoYQ4 FY25QoQ
Revenue from operations185.91154.52+20.3%167.18+11.2%
Other income8.856.99+26.6%8.74+1.2%
Total income194.76161.52+20.6%175.92+10.7%
Profit before tax54.9048.67+12.8%43.46+26.3%
Net profit for the period40.4434.98+15.6%26.73+51.3%
Attributable to shareholders of the company39.9334.15+16.9%26.48+50.8%
EPS, basic (₹)3.573.05+17.0%2.37+50.6%
Net margin (%)21.822.616.0
Standalone · ₹ crore
ItemQ1 FY26Q1 FY25YoYQ4 FY25QoQ
Revenue from operations125.0285.96+45.4%87.21+43.4%
Other income53.8553.88−0.0%4.5312x
Total income178.88139.83+27.9%91.74+95.0%
Profit before tax81.4072.16+12.8%15.51+424.8%
Net profit for the period73.9867.06+10.3%11.05+569.3%
EPS, basic (₹)6.616.00+10.2%0.99+567.7%
Net margin (%)59.278.012.7
Consolidated
Filed with BSE
02 Aug 2025, 15:07 IST
Board meeting
02 Aug 2025
Period
01 Apr 2025 to 30 Jun 2025
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
02 Aug 2025, 15:07 IST
Board meeting
02 Aug 2025
Period
01 Apr 2025 to 30 Jun 2025
Review status
Unaudited
Source
XBRL filing on BSE